NEW YORK (GenomeWeb News) – Integrated Genomics has extended a license agreement with TMO Renewables for IG’s ERGO software for use in a cellulosic ethanol development program.
Under the agreement, TMO will use IG’s software to identify pathways that can be used to upgrade TMO’s cellulosic ethanol program. Initially, the company plans to focus on its membrane transport proteins in its thermophilic strain.
The software is used to integrate biological data from genomics research, gene expression studies, genetics, and from sources in literature.
TMO’s ethanol production uses “high-temperature process organisms capable of producing bioethanol quickly and efficiently from a wide diversity of sustainable cellulosic feedstocks,” said Kirstin Eley, external program manager at TMO.
The ERGO software contains over 1,350 genomes that are in various stages of completion and more than 6,000 networked metabolic and non-metabolic pathways.
Financial terms of the agreement were not released.